¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07±³À°ÀÏÀÚ : 2018-09-07
±³À°Àå¼Ò : ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø ¿Ü·¡¼¾ÅÍ 7Ãþ ´ëȸÀǽÇ
±³À°ÁÖÁ¦ :
NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] ÁÖÃÖ±â°ü : ¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³»°úÇб³½Ç
´ã´çÀÚ : ±èÈñ³²
¿¬¶ôó : 033-732-0401
À̸ÞÀÏ :
kchri2011@naver.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
°¿øµµ±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 13:30~13:50 Current status of cardiometabolic syndrome in Korea ÇãÁöÇý(¿¬¼¼¿øÁÖÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 13:50~14:10 The trends for incidence of cardiovascular disease and mortality in patients with metabolic syndrome À̹̿µ(¿¬¼¼¿øÁÖÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 14:10~14:30 Obesity paradox in congestive heart failure À¯º´¼ö(¿¬¼¼¿øÁÖÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 14:30~14:50 Obesity, cardiometabolic syndrome and risk of atrial fibrillation ¾È¹Î¼ö(¿¬¼¼¿øÁÖÀÇ´ë ½ÉÀå³»°ú)
Åä·Ð 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 14:50~15:10 panel discussion ()
ÈÞ½Ä 09¿ù 07ÀÏ 15:10~15:30 Coffee Break ()
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 15:30~16:00 Keynote lecture: NAFLD: what it is, should we worry, and what do we need to know? Christopher D. Byrne(University of Southampton)
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 16:00~16:20 NAFLD in Asia °¼ºÈñ(¿¬¼¼¿øÁÖÀÇ´ë ¼Òȱ⳻°ú)
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 16:20~16:40 Screening and diagnosis for NAFLD in clinical practice ±è¹®¿µ(¿¬¼¼¿øÁÖÀÇ´ë ¼Òȱ⳻°ú)
±³À°½Ã°£ 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 16:40~17:00 Current and future therapies for NAFLD ¼º±âö(¼º±Õ°üÀÇ´ë ½ÉÀå³»°ú)
Åä·Ð 09¿ù 07ÀÏ ´ëȸÀÇ½Ç 17:00~17:20 panel discussion ()